Cargando…
The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists
The coronavirus disease 2019 (COVID-19) pandemic has elicited many health concerns, including the impact of the infection and vaccine on reproductive health. Although robust evidence demonstrates the safety of all available COVID-19 vaccines, misinformation and disinformation related to the vaccine...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831663/ https://www.ncbi.nlm.nih.gov/pubmed/36775738 http://dx.doi.org/10.1016/j.japh.2023.01.003 |
_version_ | 1784867893076295680 |
---|---|
author | Vernon, Veronica Patel, Jaini Cieri-Hutcherson, Nicole E. Arellano, Regina Elmore, Hannah Griffin, Brooke L. Mitzel, Kayla Moyeno, Wandyenid Márquez O’Connell, Mary Beth Pelaccio, Karli Lodise, Nicole M. |
author_facet | Vernon, Veronica Patel, Jaini Cieri-Hutcherson, Nicole E. Arellano, Regina Elmore, Hannah Griffin, Brooke L. Mitzel, Kayla Moyeno, Wandyenid Márquez O’Connell, Mary Beth Pelaccio, Karli Lodise, Nicole M. |
author_sort | Vernon, Veronica |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic has elicited many health concerns, including the impact of the infection and vaccine on reproductive health. Although robust evidence demonstrates the safety of all available COVID-19 vaccines, misinformation and disinformation related to the vaccine continue to circulate. As accessible and essential health care workers, it is crucial that pharmacists are informed of the evidence related to effects of the COVID-19 infection and vaccinations on reproductive health care. Menstrual cycle changes have been noted owing to COVID-19 infection, pandemic stress, and COVID-19 vaccination. COVID-19 infection and vaccination have not been shown to influence female fertility, pregnancy rates, and lactation. The use of exogenous estrogen may further contribute to an increased risk of thromboembolism with COVID-19 infection, and differences in the risk of cerebral venous sinus thrombosis appear to exist between the types of vaccines. The benefits of COVID-19 vaccination outweigh any risks. Shared decision-making is necessary when discussing vaccination with patients. Pharmacists play a vital role in dispelling misinformation and disinformation related to the impact of COVID-19 illness and vaccination on reproductive health care. |
format | Online Article Text |
id | pubmed-9831663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Pharmacists Association®. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98316632023-01-11 The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists Vernon, Veronica Patel, Jaini Cieri-Hutcherson, Nicole E. Arellano, Regina Elmore, Hannah Griffin, Brooke L. Mitzel, Kayla Moyeno, Wandyenid Márquez O’Connell, Mary Beth Pelaccio, Karli Lodise, Nicole M. J Am Pharm Assoc (2003) Commentary The coronavirus disease 2019 (COVID-19) pandemic has elicited many health concerns, including the impact of the infection and vaccine on reproductive health. Although robust evidence demonstrates the safety of all available COVID-19 vaccines, misinformation and disinformation related to the vaccine continue to circulate. As accessible and essential health care workers, it is crucial that pharmacists are informed of the evidence related to effects of the COVID-19 infection and vaccinations on reproductive health care. Menstrual cycle changes have been noted owing to COVID-19 infection, pandemic stress, and COVID-19 vaccination. COVID-19 infection and vaccination have not been shown to influence female fertility, pregnancy rates, and lactation. The use of exogenous estrogen may further contribute to an increased risk of thromboembolism with COVID-19 infection, and differences in the risk of cerebral venous sinus thrombosis appear to exist between the types of vaccines. The benefits of COVID-19 vaccination outweigh any risks. Shared decision-making is necessary when discussing vaccination with patients. Pharmacists play a vital role in dispelling misinformation and disinformation related to the impact of COVID-19 illness and vaccination on reproductive health care. American Pharmacists Association®. Published by Elsevier Inc. 2023 2023-01-11 /pmc/articles/PMC9831663/ /pubmed/36775738 http://dx.doi.org/10.1016/j.japh.2023.01.003 Text en © 2023 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Vernon, Veronica Patel, Jaini Cieri-Hutcherson, Nicole E. Arellano, Regina Elmore, Hannah Griffin, Brooke L. Mitzel, Kayla Moyeno, Wandyenid Márquez O’Connell, Mary Beth Pelaccio, Karli Lodise, Nicole M. The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists |
title | The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists |
title_full | The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists |
title_fullStr | The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists |
title_full_unstemmed | The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists |
title_short | The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists |
title_sort | impact of covid-19 on select considerations in patients of reproductive age: brief talking points for pharmacists |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831663/ https://www.ncbi.nlm.nih.gov/pubmed/36775738 http://dx.doi.org/10.1016/j.japh.2023.01.003 |
work_keys_str_mv | AT vernonveronica theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT pateljaini theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT cierihutchersonnicolee theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT arellanoregina theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT elmorehannah theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT griffinbrookel theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT mitzelkayla theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT moyenowandyenidmarquez theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT oconnellmarybeth theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT pelacciokarli theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT lodisenicolem theimpactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT vernonveronica impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT pateljaini impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT cierihutchersonnicolee impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT arellanoregina impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT elmorehannah impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT griffinbrookel impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT mitzelkayla impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT moyenowandyenidmarquez impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT oconnellmarybeth impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT pelacciokarli impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists AT lodisenicolem impactofcovid19onselectconsiderationsinpatientsofreproductiveagebrieftalkingpointsforpharmacists |